Insiders / Thorp Clay
Thorp Clay
CIK 1592380personinsider
Companies
3
First seen
Feb 12, 2021
Last activity
Feb 24, 2025
Companies
| Company | Shares held | Latest |
|---|---|---|
| Clearside Biomedical, Inc. · CLSD | 3,721,181 | — |
| PhaseBio Pharmaceuticals Inc · PHAS | 3,581,733 | — |
| Vigil Neuroscience, Inc. · VIGL | 1,559,030 | — |
All securities held
5 positions · latest reported per filing
Shares
| Company | Security | Shares |
|---|---|---|
| Clearside Biomedical, Inc. | Common stock | 3,721,181 |
| PhaseBio Pharmaceuticals Inc | Common stock | 3,581,733 |
| Vigil Neuroscience, Inc. | Common stock | 1,559,030 |
Derivatives
| Company | Security | Shares |
|---|---|---|
| Clearside Biomedical, Inc. | Options | 45,000 |
| PhaseBio Pharmaceuticals Inc | Options | 17,500 |
Ownership percentages elsewhere on the site count common and ordinary shares only, because that is what shares outstanding are measured in. Everything above is a real holding; not all of it is a share of the company.
Activity
InsidersInstitutions
This person's trades in company stock, across every company.| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Jan 11, 2022 | Buy Open-market buy | VIGL Vigil Neuroscience, Inc. Common Stock | $3.71M | +265K +21.13% | 1,519,335 | high |
| Feb 10, 2021 | Sell Open-market sale | CLSD Clearside Biomedical, Inc. Common Stock | $145.6K | -33K -0.95% | 3,433,521 | medium |
| Feb 10, 2021 | Sell Open-market sale | CLSD Clearside Biomedical, Inc. Common Stock | $145.6K |